Methaqualone pharmacokinetics after single- and multiple-dose administration in man. 1974

R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008702 Methaqualone A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604) Metolquizolone,Ortonal,Methaqualone Hydrochloride,Optimil,Quaalude,Hydrochloride, Methaqualone
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011329 Prisoners Persons deprived of their liberty; those held is against their will, or who are kept in confinement or custody. Detained Persons,Hostages,Imprisoned Individuals,Incarcerated Individuals,Inmates,Detained Person,Hostage,Imprisoned Individual,Incarcerated Individual,Individual, Imprisoned,Individual, Incarcerated,Inmate,Person, Detained,Prisoner
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
March 1984, Archives of toxicology,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
January 1985, Arzneimittel-Forschung,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
January 1987, Biopharmaceutics & drug disposition,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
April 2009, American journal of veterinary research,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
January 2011, Journal of biomedical research,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
October 1974, European journal of clinical pharmacology,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
December 1987, Journal of clinical pharmacology,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
June 2004, Antimicrobial agents and chemotherapy,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
January 1993, Drugs & aging,
R K Nayak, and R D Smyth, and J H Chamberlain, and A Polk, and A F DeLong, and T Herczeg, and P B Chemburkar, and R S Joslin, and N H Reavey-Cantwell
December 2018, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!